Device
Reveal LINQ
Reveal LINQ is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
100%(2 trials)
Phase Distribution
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
unknown125%
active_not_recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
completed
Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)
NCT04169529
active_not_recruitingnot_applicable
Obstructive Sleep Apnoea and Cardiac Arrhythmias
NCT03866148
completed
Reveal LINQ Registry
NCT02746471
unknownnot_applicable
Frailty and Falls Implantable System for Prediction and Prevention
NCT04881136
Clinical Trials (4)
Showing 4 of 4 trials
NCT04169529
Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)
NCT03866148Not Applicable
Obstructive Sleep Apnoea and Cardiac Arrhythmias
NCT02746471
Reveal LINQ Registry
NCT04881136Not Applicable
Frailty and Falls Implantable System for Prediction and Prevention
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4